MX377199B - Nuevo compuesto aislado a partir de pseudolysimachion rotundum var. subintegrum que contiene cantidades abundantes del ingrediente activo, la composicion que lo comprende para prevenir o tratar la enfermedad alergica, enfermedad inflamatoria, asma o enfermedad pulmonar obstructiva cronica y el uso del mismo. - Google Patents

Nuevo compuesto aislado a partir de pseudolysimachion rotundum var. subintegrum que contiene cantidades abundantes del ingrediente activo, la composicion que lo comprende para prevenir o tratar la enfermedad alergica, enfermedad inflamatoria, asma o enfermedad pulmonar obstructiva cronica y el uso del mismo.

Info

Publication number
MX377199B
MX377199B MX2017000991A MX2017000991A MX377199B MX 377199 B MX377199 B MX 377199B MX 2017000991 A MX2017000991 A MX 2017000991A MX 2017000991 A MX2017000991 A MX 2017000991A MX 377199 B MX377199 B MX 377199B
Authority
MX
Mexico
Prior art keywords
disease
asthma
active ingredient
composition
chronic obstructive
Prior art date
Application number
MX2017000991A
Other languages
English (en)
Other versions
MX2017000991A (es
Inventor
Byung-Hwan Ryoo
Dae-Hee Shin
Hyeong-Kyu Lee
Hyuk-Hwan Song
Hyung Won Ryu
In-Sik Shin
Ji-Seok Yoo
Kyung-Seop Ahn
Sei-Ryang Oh
Su Ui Lee
Yongnam Lee
Original Assignee
Yungjin Pharmaceutical Co Ltd
Korea Res Inst Bioscience & Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55163923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX377199(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yungjin Pharmaceutical Co Ltd, Korea Res Inst Bioscience & Biotechnology filed Critical Yungjin Pharmaceutical Co Ltd
Publication of MX2017000991A publication Critical patent/MX2017000991A/es
Publication of MX377199B publication Critical patent/MX377199B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se relaciona con un (3R,5S,5aS,6R,7S,8R,8aS)-8-cloro-8ª hidroxi-5-(2- hidroxi acetoxi)hexahidro-1H-3,6-metanociclopenta[e][1,3]dioxepin-7-il 3,4-dihidroxibenzoato (KS534), el isomero de este, la sal o solvatos farmaceuticamente aceptables de este, una composicion que comprende el mismo como un ingrediente activo para la prevencion o tratamiento de la enfermedad alergica, la enfermedad inflamatoria, el asma o la enfermedad pulmonar obstructiva cronica (COPD) y su uso.
MX2017000991A 2014-07-24 2015-07-22 Nuevo compuesto aislado a partir de pseudolysimachion rotundum var. subintegrum que contiene cantidades abundantes del ingrediente activo, la composicion que lo comprende para prevenir o tratar la enfermedad alergica, enfermedad inflamatoria, asma o enfermedad pulmonar obstructiva cronica y el uso del mismo. MX377199B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140094023A KR101638795B1 (ko) 2014-07-24 2014-07-24 산꼬리풀 추출물로부터 분리된 신규 화합물 및 이를 유효성분으로 포함하는 알러지, 염증, 천식 또는 만성 폐쇄성 폐질환의 예방 또는 치료용 조성물
PCT/KR2015/007647 WO2016013877A2 (en) 2014-07-24 2015-07-22 A novel compound isolated from pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the composition comprising the same for preventing or treating allergy disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof

Publications (2)

Publication Number Publication Date
MX2017000991A MX2017000991A (es) 2017-03-14
MX377199B true MX377199B (es) 2025-03-07

Family

ID=55163923

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000991A MX377199B (es) 2014-07-24 2015-07-22 Nuevo compuesto aislado a partir de pseudolysimachion rotundum var. subintegrum que contiene cantidades abundantes del ingrediente activo, la composicion que lo comprende para prevenir o tratar la enfermedad alergica, enfermedad inflamatoria, asma o enfermedad pulmonar obstructiva cronica y el uso del mismo.

Country Status (13)

Country Link
US (1) US20170217982A1 (es)
EP (1) EP3172191B1 (es)
JP (1) JP2017523171A (es)
KR (1) KR101638795B1 (es)
CN (1) CN106795170B (es)
AU (1) AU2015292962B2 (es)
BR (1) BR112017001364A2 (es)
CA (1) CA2954371C (es)
ES (1) ES2736136T3 (es)
MX (1) MX377199B (es)
PL (1) PL3172191T3 (es)
RU (1) RU2685732C2 (es)
WO (1) WO2016013877A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250044966A (ko) 2023-09-25 2025-04-01 주식회사 웰아이피에스 벚나무 추출물을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2233668C1 (ru) * 2003-05-20 2004-08-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Способ получения препарата фенольной природы из растительного сырья
KR100860080B1 (ko) * 2005-05-30 2008-09-24 한국생명공학연구원 항염, 항알레르기 및 항천식 활성을 갖는 꼬리풀속 식물추출물을 함유하는 약학조성물
KR20060125499A (ko) * 2005-05-30 2006-12-06 한국생명공학연구원 항염, 항알레르기 및 항천식 활성을 갖는 긴산꼬리풀추출물로부터 분리된 카탈폴 유도체를 함유하는 약학조성물
ES2368255T3 (es) * 2005-05-30 2011-11-15 Korea Research Institute Of Bioscience And Biotechnology Composición farmacéutica que comprende un extracto de pseudolysimachion longifolium y los derivados de catapol aislados a partir de este, que tiene actividad antiinflamatoria, antialergica y antiasmática.
KR100991279B1 (ko) * 2008-05-08 2010-11-01 경북대학교 산학협력단 담쟁이덩굴 추출물로부터 분리된 신규 화합물을유효성분으로 함유하는 염증성 질환의 예방 및 치료용조성물
KR101476045B1 (ko) * 2012-12-31 2014-12-23 영진약품공업주식회사 활성성분을 다량 함유한 산꼬리풀 정제 분획물 (atc2), 이의 제조방법 및 이를 유효성분으로 포함하는 염증, 알레르기 및 천식의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
CN106795170B (zh) 2018-11-09
KR101638795B1 (ko) 2016-07-12
WO2016013877A3 (en) 2016-07-21
JP2017523171A (ja) 2017-08-17
BR112017001364A2 (pt) 2017-11-21
MX2017000991A (es) 2017-03-14
EP3172191A4 (en) 2018-01-03
RU2017102042A3 (es) 2019-01-14
CN106795170A (zh) 2017-05-31
US20170217982A1 (en) 2017-08-03
RU2685732C2 (ru) 2019-04-23
AU2015292962A1 (en) 2017-01-12
CA2954371A1 (en) 2016-01-28
AU2015292962B2 (en) 2019-03-14
CA2954371C (en) 2019-05-21
WO2016013877A2 (en) 2016-01-28
RU2017102042A (ru) 2018-08-27
EP3172191A2 (en) 2017-05-31
KR20160012498A (ko) 2016-02-03
PL3172191T3 (pl) 2019-12-31
ES2736136T3 (es) 2019-12-26
EP3172191B1 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
MX390302B (es) Oxiesteroles y metodos de uso de los mismos
CU20190045A7 (es) Compuestos derivados de 1,2,4-triazolonas 2,4,5-trisustituidas que son inhibidores de la dihidroorotato deshidrogenasa (dhodh) útiles para el tratamiento o prevención de trastornos hiperproliferativos e inflamatorios
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
PH12014502363A1 (en) N-aryltriazole compounds as lpar antagonists
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
PH12014502789A1 (en) N-alkyltriazole compounds as lpar antagonists
MX2020010690A (es) Oxiesteroles y metodos de uso de los mismos.
TN2016000081A1 (en) Aminoheteroaryl benzamides as kinase inhibitors
WO2015200481A8 (en) Mnk inhibitors and methods related thereto
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
MX2018001990A (es) Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac.
HK1255500A1 (zh) 氧固醇及其使用方法
UY35972A (es) Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos
TN2017000075A1 (en) Compounds and compositions as raf kinase inhibitors
PH12017502051A1 (en) TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
MX2017014035A (es) Formas solidas novedosas.
WO2015191754A3 (en) Phosphatidylinositol 3-kinase inhibitors
MX379859B (es) Compuestos de indolinona y su uso en el tratamiento de enfermedades fibróticas.
PH12014502364A1 (en) Substituted pyrazole compounds as lpar antagonists
MX2022000945A (es) Composicion para incrementar la expresion de pgc-1alfa.
WO2013152277A3 (en) Moenomycin analogs, methods of synthesis, and uses thereof
MX382175B (es) Composiciones de profármaco de monometilfumarato
WO2015150449A3 (en) Amido-substituted azole compounds as inhibitors of tnks1 and/or tnks2

Legal Events

Date Code Title Description
FG Grant or registration